PD-1/PD-L1 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF
Provided are a compound as a PD-L1 inhibitor, a preparation method therefor, and use thereof. Further provided is use of the compound or a pharmaceutical composition thereof in the preparation of a medicine, wherein the medicine is used for preventing and treating a PD-L1-related disease..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 13. Apr. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
XU XIN [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-04-13, Last update posted on www.tib.eu: 2023-06-16, Last updated: 2023-06-23 |
|---|
| Patentnummer: |
US2023111910 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA016980395 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA016980395 | ||
| 003 | DE-627 | ||
| 005 | 20230623182450.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230613s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA016980395 | ||
| 035 | |a (EPA)US2023111910 | ||
| 035 | |a (EPA)76993075 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a XU XIN |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a PD-1/PD-L1 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-04-13, Last update posted on www.tib.eu: 2023-06-16, Last updated: 2023-06-23 | ||
| 520 | |a Provided are a compound as a PD-L1 inhibitor, a preparation method therefor, and use thereof. Further provided is use of the compound or a pharmaceutical composition thereof in the preparation of a medicine, wherein the medicine is used for preventing and treating a PD-L1-related disease. | ||
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a CHEN JIA |4 aut | |
| 700 | 0 | |a ZHANG LIMING |4 aut | |
| 700 | 0 | |a YANG XUQIN |4 aut | |
| 700 | 0 | |a YANG MAOZHI |4 aut | |
| 700 | 0 | |a ZHANG XIAOJUAN |4 aut | |
| 700 | 0 | |a XU YANXIAO |4 aut | |
| 700 | 0 | |a ZHOU XIAOBO |4 aut | |
| 700 | 0 | |a YU HAO |4 aut | |
| 700 | 0 | |a ZHANG YUYUN |4 aut | |
| 700 | 0 | |a WANG YING |4 aut | |
| 700 | 0 | |a XIA XIAOER |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 13. Apr. |
| 773 | 1 | 8 | |g year:2023 |g day:13 |g month:04 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/76993075/publication/US2023111910A1?q=US2023111910 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 13 |c 04 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 13 |c 04 | ||